Literature DB >> 21881090

Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers.

Iain Chalmers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21881090      PMCID： PMC3164257          DOI： 10.1258/jrsm.2011.11k023

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  15 in total

1.  Why transition from alternation to randomisation in clinical trials was made.

Authors:  I Chalmers
Journal:  BMJ       Date:  1999-11-20

2.  Casting and drawing lots: a time honoured way of dealing with uncertainty and ensuring fairness.

Authors:  W A Silverman; I Chalmers
Journal:  BMJ       Date:  2001 Dec 22-29

3.  The introduction of mathematical statistics into medical research: the roles of Karl Pearson, Major Greenwood and Austin Bradford Hill.

Authors:  Eileen Magnello
Journal:  Clio Med       Date:  2002

4.  ON RECENT PROGRESS IN THE SERUMTHERAPY OF PLAGUE.

Authors:  K B Choksy
Journal:  Br Med J       Date:  1908-05-30

5.  THE SERUM TREATMENT OF LOBAR PNEUMONIA: A REPORT OF THE THERAPEUTIC TRIALS COMMITTEE OF THE MEDICAL RESEARCH COUNCIL.

Authors: 
Journal:  Br Med J       Date:  1934-02-10

6.  Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial.

Authors:  Scott H Podolsky
Journal:  J R Soc Med       Date:  2009-05       Impact factor: 5.344

7.  STREPTOMYCIN treatment of pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1948-10-30

Review 8.  Assembling comparison groups to assess the effects of health care.

Authors:  I Chalmers
Journal:  J R Soc Med       Date:  1997-07       Impact factor: 5.344

9.  The controlled trial.

Authors:  R Doll
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

10.  Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council.

Authors:  Iain Chalmers; Mike Clarke
Journal:  Int J Epidemiol       Date:  2004-04       Impact factor: 7.196
View more
  14 in total

1.  Why the MRC therapeutic trials committee did not introduce controlled clinical trials.

Authors:  Ben Toth
Journal:  J R Soc Med       Date:  2015-12       Impact factor: 5.344

2.  UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2013-12       Impact factor: 5.344

3.  The Medical Research Council and clinical trial methodologies before the 1940s: the failure to develop a 'scientific' approach.

Authors:  Linda Bryder
Journal:  J R Soc Med       Date:  2011-08       Impact factor: 5.344

Review 4.  Management of non-syndromic dens evaginatus affecting permanent maxillary central incisors: a systematic review.

Authors:  Violaine Smail-Faugeron; Julie Picou Rollin; Michèle Muller Bolla; Frederic Courson
Journal:  BMJ Case Rep       Date:  2016-10-05

5.  Julius Wagner-Jauregg: pyrotherapy, simultanmethode, and 'racial hygiene'.

Authors:  G Gartlehner; K Stepper
Journal:  J R Soc Med       Date:  2012-08       Impact factor: 5.344

Review 6.  Management of non-syndromic double tooth affecting permanent maxillary central incisors: a systematic review.

Authors:  Violaine Smail-Faugeron; Jeanne Terradot; Michèle Muller Bolla; Frederic Courson
Journal:  BMJ Case Rep       Date:  2016-06-15

7.  Italian controlled trials to assess prevention and treatment of malaria, 1900-1930s.

Authors:  Silvio Garattini
Journal:  J R Soc Med       Date:  2019-08       Impact factor: 18.000

Review 8.  Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements.

Authors:  Arif Khan; Kaysee Fahl Mar; Walter A Brown
Journal:  Psychopharmacol Bull       Date:  2021-06-01

9.  John Henry Gaddum's 1940 guidance on controlled clinical trials.

Authors:  P Marson Smith; D Colquhoun; I Chalmers
Journal:  J R Soc Med       Date:  2019-09       Impact factor: 18.000

10.  Injury and death in clinical trials and compensation: Rule 122 DAB.

Authors:  Ravindra B Ghooi
Journal:  Perspect Clin Res       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.